Biktarvy’s list price is $4,216 per month. Without insurance, that number can feel impossible. But the reality for most uninsured patients is different: the majority qualify for programs that bring the cost to $0. The problem is rarely eligibility — it’s knowing where to apply, in what order, and exactly what to submit.
This guide covers every program available to uninsured patients in 2026, with step-by-step enrollment instructions, income and eligibility requirements for each, state-specific detail for ADAP, and a clear decision path for patients who have been turned away before.
Do not stop Biktarvy while pursuing assistance. Interrupting antiretroviral therapy can cause viral rebound, immune system decline, and drug resistance mutations that narrow future treatment options. If you cannot afford your next fill, call your prescriber and Gilead’s helpline (1-800-226-2056) today — bridge supplies are available while applications are processed.
Which Program Should You Apply to First?
The right starting point depends on your income, location, and how quickly you need medication. Here is the recommended sequence for an uninsured patient with a valid Biktarvy prescription:
This is the fastest path to a bridge supply while other applications are processed. Gilead can verify preliminary PAP eligibility by phone and initiate a medication bridge. Income up to ~500% FPL. Available in all states.
ADAP is a government program with consistent state oversight — it should run in parallel with Gilead PAP, not as a backup. Find your state program at nastad.org/adap-watch. Processing varies from days to weeks by state.
If you are in a Medicaid expansion state and earn at or below 138% of the federal poverty level (~$20,800 for a single person in 2026), you may qualify for Medicaid immediately. Apply at healthcare.gov or your state Medicaid agency.
If you don’t have a prescribing clinician, or if you need care immediately, use findhivcare.hrsa.gov. Ryan White clinics provide HIV care and medications regardless of ability to pay. Many operate 340B pricing programs that significantly reduce medication costs.
The Patient Advocate Foundation, PAN Foundation, and HealthWell Foundation can supplement or bridge gaps in coverage. Apply simultaneously with the above — do not wait for one program to be rejected before applying to another.
Program 1: Gilead Advancing Access — Patient Assistance Program (PAP)
Eligibility Requirements
- No adequate prescription drug insurance coverage (uninsured or insurance that does not cover Biktarvy)
- Income generally at or below 500% of the federal poverty level — approximately $75,300 for a single person in 2026 (Gilead evaluates each case individually; patients above this threshold may still be considered)
- Valid, current Biktarvy prescription from a licensed U.S. healthcare provider
- Must be a U.S. resident
Step-by-Step Enrollment
-
1Call 1-800-226-2056 or visit GileadAdvancingAccess.com. A program specialist will assess your situation and determine which program you qualify for — PAP for uninsured patients or the copay card for those with commercial insurance. Multilingual support is available.
-
2Request the PAP enrollment forms. These can be mailed, emailed, or downloaded from the website. Your prescriber’s office must complete the prescriber section — call your clinic to let them know forms are coming. Many clinic staff are familiar with this process.
-
3Gather your income documentation. Acceptable documents include: most recent federal tax return (Form 1040), two to three recent pay stubs, a Social Security award letter, or a signed income attestation if you have no formal income documentation. Self-employed patients can submit a profit/loss statement or signed attestation.
-
4Document your insurance status. Provide one of the following: a letter from an insurer confirming no coverage, a letter from your employer confirming no prescription drug benefit, a signed attestation that you are uninsured, or documentation of a coverage denial for Biktarvy specifically.
-
5Submit the complete package. Incomplete applications are the most common cause of delay. Confirm with the specialist that all required sections — patient, prescriber, and supporting documents — are complete before submitting. Fax is typically the fastest submission method; the fax number is on the enrollment form.
-
6Ask about a bridge supply. When you call to submit or follow up, explicitly ask: “Can I receive a bridge supply while my application is being reviewed?” Gilead can often arrange an interim medication supply to prevent treatment interruption during the 2–4 week processing window. Your prescriber may need to request this.
-
7Follow up at 10 business days. If you have not received a decision after 10 business days, call 1-800-226-2056 to check status. Have your application reference number ready. If additional documents are needed, they will tell you at this point — providing them promptly restarts the clock.
-
8Renew annually. PAP enrollment lasts 12 months. Gilead will contact you before expiration, but set a reminder for 60 days before your enrollment ends to begin renewal paperwork. Income re-verification is required at renewal.
Program 2: AIDS Drug Assistance Program (ADAP)
ADAP is administered separately in each state under the Ryan White HIV/AIDS Program (Part B). While the federal framework is consistent, the income limits, formulary, documentation requirements, and waiting list status vary significantly by state.
General Eligibility Requirements (All States)
- Confirmed HIV-positive status (lab documentation required)
- U.S. resident in the state where you are applying
- Income within your state’s ADAP limit (see state table below)
- Uninsured or underinsured (coverage varies by state definition)
- Valid Biktarvy prescription from a licensed provider
Step-by-Step ADAP Enrollment
-
1Find your state’s ADAP program. Use the NASTAD ADAP locator or call your local Ryan White clinic and ask for the ADAP enrollment coordinator. Every Ryan White clinic has staff trained to help with ADAP enrollment.
-
2Confirm your state’s current income limit and waiting list status. NASTAD’s ADAP Watch (nastad.org/adap-watch) publishes updated data on income limits and waiting lists by state. Most states currently have no waiting list, but this can change during funding cycles.
-
3Gather HIV documentation. You will need a copy of a positive HIV test result, a CD4 count, and/or viral load laboratory result. Your prescribing clinician can provide this. If you do not have documentation, a Ryan White clinic can test and document your status as part of enrollment.
-
4Prepare income documentation. ADAP typically requires: recent pay stubs (2–3 months), most recent tax return, Social Security or disability award letters, or a signed income attestation for those with no documented income. Self-employed applicants can provide business records or a signed statement.
-
5Prepare residency documentation. A utility bill, lease, bank statement, or government-issued mail showing your address in the state is typically acceptable. Some states also accept a signed residency declaration.
-
6Complete the state ADAP enrollment form. Many ADAP programs have case managers who will complete the form with you in person or by phone. Ask your Ryan White clinic or local AIDS service organization (ASO) for enrollment assistance — this is a core service they provide.
-
7Submit and request expedited review if needed. If you are at risk of treatment interruption, explicitly state this in your application and to your enrollment coordinator. Many states have provisions for expedited review when clinical urgency is documented by your prescriber.
-
8Renew annually. ADAP enrollment requires annual renewal. Your state program will notify you, but do not wait for the notice — begin renewal paperwork 60 days before expiration to prevent a coverage gap.
State ADAP Income Limits — Selected States (2026)
Income limits are expressed as a percentage of the Federal Poverty Level (FPL). For a single person, 100% FPL = approximately $15,060 in 2026. Limits change annually — always verify current figures with your state ADAP directly.
| State | Income Limit (% FPL) | Approx. Single-Person Limit | Waiting List | Contact |
|---|---|---|---|---|
| California | 500% | ~$75,300 | None | CA Dept. of Public Health: 916-449-5900 |
| New York | 435% | ~$65,511 | None | NY AIDS Institute: 518-474-9936 |
| Texas | 200% | ~$30,120 | None (monitor) | TX DSHS: 512-533-3000 |
| Florida | 400% | ~$60,240 | None | FL ADAP: 850-245-4444 |
| Illinois | 400% | ~$60,240 | None | IL DPH ADAP: 217-782-2016 |
| Georgia | 300% | ~$45,180 | None | GA DPH: 404-657-3100 |
| Pennsylvania | 300% | ~$45,180 | None | PA DOH: 877-724-3258 |
| Ohio | 300% | ~$45,180 | None | OH ODH: 614-466-6579 |
| North Carolina | 300% | ~$45,180 | None | NC DHHS: 919-733-7301 |
| Michigan | 400% | ~$60,240 | None | MI MDHHS: 517-335-8371 |
| Virginia | 400% | ~$60,240 | None | VA VDH: 804-864-7900 |
| Washington | 400% | ~$60,240 | None | WA DOH: 360-236-3425 |
| Arizona | 400% | ~$60,240 | None | AZ DHS: 602-364-3610 |
| Massachusetts | 500% | ~$75,300 | None | MA DPH: 617-983-6550 |
| New Jersey | 500% | ~$75,300 | None | NJ DOH: 609-984-5874 |
Important: State ADAP income limits and waiting list status change during funding cycles. The figures above are based on published 2026 data and are provided for general guidance only. Always verify the current limit and waiting list status directly with your state program or at nastad.org/adap-watch before applying.
Program 3: Medicaid
Medicaid is a comprehensive health insurance program — it covers not just Biktarvy but all your HIV-related care, lab work, and clinician visits. If you qualify, it is often the most comprehensive option. As of 2026, 40 states and DC have adopted Medicaid expansion under the ACA, covering adults earning up to 138% of the federal poverty level.
Medicaid Expansion States (as of 2026)
States that have NOT adopted Medicaid expansion as of early 2026: Alabama, Florida, Georgia, Kansas, Mississippi, South Carolina, Tennessee, Texas, Wisconsin, and Wyoming. If you live in a non-expansion state and are uninsured, ADAP and the Gilead PAP are your primary pathways.
Step-by-Step Medicaid Enrollment
-
1Check your income against 138% FPL. For a single person in 2026, 138% FPL is approximately $20,800. For a family of two, approximately $28,200. Use the eligibility screener at healthcare.gov/screener to get an immediate estimate.
-
2Apply at healthcare.gov or your state Medicaid agency. If you are in an expansion state and meet the income threshold, you can apply online at healthcare.gov or directly through your state’s Medicaid portal. Medicaid has no open enrollment period — you can apply any time and coverage begins within days to weeks of approval.
-
3Gather documents: government-issued ID, Social Security number, proof of residency (utility bill, lease), and income documentation (pay stubs, tax return, or income attestation). In an HIV-related emergency, ask about presumptive eligibility — some states provide temporary Medicaid coverage immediately while the full application is processed.
-
4After approval, confirm Biktarvy is covered on your Medicaid plan’s formulary. Biktarvy is covered in all state Medicaid programs, but some may require prior authorization from your prescriber. Your clinic or prescriber’s office can submit prior authorization documentation if required.
-
5If you are in a non-expansion state and do not qualify for traditional Medicaid, focus on ADAP and the Gilead PAP as your primary access pathways. You may also qualify for ACA Marketplace coverage with subsidies — see Program 5 below.
Program 4: Ryan White Clinics and 340B Pricing
Ryan White clinics are a network of over 2,000 federally funded HIV care sites across the United States. By law, they cannot turn away a patient due to inability to pay. They also frequently participate in the 340B Drug Pricing Program, which allows them to dispense Biktarvy at significantly reduced prices — often at or near $0 for patients without other coverage.
What 340B Pricing Means For You
The 340B program requires drug manufacturers to sell outpatient drugs to eligible safety-net providers at prices approximately 25–50% below the wholesale acquisition cost. These facilities can then use the savings to reduce patient costs. For an uninsured patient receiving care at a 340B-participating Ryan White clinic, this can mean Biktarvy is available at minimal or no cost through the clinic’s in-house or contract pharmacy.
Step-by-Step: Getting Biktarvy Through a Ryan White Clinic
-
1Find your nearest Ryan White clinic. Use the HRSA HIV Care Locator at findhivcare.hrsa.gov. You can search by ZIP code, city, or state. The results show clinic type, services offered, and contact information.
-
2Call to schedule an intake appointment. Ask specifically: “Do you take patients without insurance?” and “Does your clinic participate in the 340B drug pricing program?” The answer to both should be yes at a Ryan White-funded clinic. If you are in a crisis, explain you may be at risk of treatment interruption — many clinics have expedited intake for this scenario.
-
3Complete the sliding-scale financial assessment at intake. Ryan White clinics use a sliding fee scale based on income and family size. Most uninsured patients with low to moderate income pay $0 or a nominal fee. Bring any income documentation you have, but clinics can work with patients who have no documentation.
-
4Ask the clinic to enroll you in ADAP simultaneously. Most Ryan White clinics have ADAP enrollment coordinators on staff. They will often handle ADAP enrollment for you as part of the intake process. This is a free service — you do not need to navigate the state program on your own.
-
5Ask about the clinic’s 340B pharmacy. If the clinic has an in-house or contract 340B pharmacy, ask to have your Biktarvy prescription routed there. This is usually the lowest-cost dispensing option for uninsured patients receiving care at that facility.
Program 5: ACA Marketplace Coverage With Subsidies
If you are uninsured but earning above Medicaid limits, you may qualify for heavily subsidized coverage through the ACA Marketplace that effectively costs less than paying full price for Biktarvy out of pocket. Under current law, any person earning between 100% and 400% FPL qualifies for premium tax credits — and in some cases, plans are available for $0 in monthly premium after subsidies.
When to consider this route: If your income is between $15,060 and $60,240 (single person, 2026) and you are in a non-Medicaid expansion state, the Marketplace may be your most comprehensive coverage option. Enroll during Open Enrollment (November 1 – January 15) or during a Special Enrollment Period triggered by a qualifying life event such as job loss.
HIV and Biktarvy under Marketplace plans: All ACA Marketplace plans must cover HIV treatment without lifetime limits and cannot deny you coverage based on a pre-existing condition. However, formulary placement and cost-sharing for Biktarvy varies by plan. When comparing plans, specifically search for Biktarvy in each plan’s drug formulary before enrolling. Once enrolled, Gilead’s copay card can reduce your out-of-pocket cost to $0–$5 per month.
Low-income subsidy note: If your income is between 100% and 150% FPL, you may qualify for a $0 premium Silver plan with very low cost-sharing through Enhanced Direct Enrollment. Use the subsidy calculator at kff.org/subsidy-calculator to estimate your premium and out-of-pocket exposure before applying.
Program 6: Nonprofit Copay and Access Foundations
Patient Advocate Foundation (PAF)
The PAF Copay Relief Program provides financial assistance for HIV/AIDS medications including Biktarvy. Eligibility criteria include a confirmed diagnosis, financial need, and U.S. residency. PAF also provides free Case Management Services — professional advocates who can help you navigate insurance denials, ADAP enrollment, and access to emergency assistance. Call 1-800-532-5274 or apply at patientadvocate.org.
Patient Access Network (PAN) Foundation
PAN Foundation HIV-related funds provide grants for copays, deductibles, insurance premiums, and other out-of-pocket costs. Fund availability fluctuates; check current open enrollment periods at panfoundation.org or call 1-866-316-7263. Apply online when a fund is open — grants are awarded on a first-come, first-served basis.
HealthWell Foundation
HealthWell maintains a HIV/AIDS assistance fund that helps with out-of-pocket treatment costs. Like PAN, fund status changes based on donations. Check current fund availability at healthwellfoundation.org or call 1-800-675-8416. If a fund is closed, request to be placed on a waitlist.
NeedyMeds
NeedyMeds.org is a free database that aggregates patient assistance programs, drug discount cards, and free clinic locations. Search by drug name or by your location. It also lists state-specific programs that may not appear in national databases.
Strategy note: Do not wait for one foundation to reject you before applying to another. Apply to all relevant programs simultaneously. Fund availability and eligibility criteria differ, and a rejection from one does not predict rejection from another. Your Ryan White clinic’s social worker can help manage multiple applications at once.
State-Specific Programs Beyond ADAP
Several states operate supplemental HIV assistance programs that go beyond ADAP. These vary significantly in scope and funding but can provide additional coverage, services, or income limits that differ from the base ADAP program.
| State | Program | What It Adds Beyond ADAP | Contact |
|---|---|---|---|
| California | CA Office of AIDS (OA) | Supplements ADAP; provides case management, clinical referrals, and coordination with Medi-Cal | cdph.ca.gov |
| New York | NY AIDS Institute | Administers NY ADAP (HIPP); provides Health Insurance Premium Payment program covering insurance premiums for eligible patients | health.ny.gov |
| Florida | FL HIV/AIDS Section | Ryan White Part B supplemental services; client services coordination; medication management | 850-245-4444 |
| Texas | TX HIV Medication Program (THMP) | ADAP equivalent administered by DSHS; includes formulary of 80+ drugs; limited waitlist possible at some income levels | dshs.texas.gov |
| Illinois | IL AIDS Drug Assistance Program | Separate formulary from ADAP with supplemental coverage for comorbidities; coordinated with Illinois Medicaid | dph.illinois.gov |
| New Jersey | NJ ADAP / NJ Sharing Network | 500% FPL income limit; broad formulary; coordinates with NJ FamilyCare (Medicaid) | nj.gov |
| Washington | WA ADAP / HCAM Program | Health Care Authority Medication program; includes premium assistance for marketplace plans | doh.wa.gov |
Program details and availability change with state budget cycles. Verify current program status directly with each state agency before applying.
What to Do If Every Program Says No
A rejection from one program is not a final answer. Before accepting that you have exhausted your options, work through the following:
- Request a written explanation of every denial. Rejections based on income are sometimes calculated incorrectly. If you believe your income was assessed inaccurately, ask for a supervisor review and bring documentation. A $1 difference in calculated income can cross an eligibility threshold incorrectly.
- Ask your prescriber to document medical necessity and financial hardship. A letter from your HIV specialist stating that treatment interruption poses a direct health risk can be submitted with reconsideration requests to both Gilead and your state ADAP program. This often carries weight in borderline decisions.
- Contact your local AIDS service organization (ASO). Every major U.S. city has a local ASO — organizations like GMHC (New York), Being Alive (Los Angeles), AID Atlanta, or Howard Brown Health (Chicago). These organizations have patient navigators who work with manufacturers and state agencies daily and often have relationships that individual patients do not. Use hivcare.org to find your local ASO.
- Contact the Patient Advocate Foundation. PAF provides free professional case management for patients who have been denied coverage or assistance. Their advocates can file appeals, identify overlooked programs, and negotiate with insurance companies and manufacturers on your behalf. Call 1-800-532-5274.
- Ask your prescriber about a clinical alternative with better access. Several HIV regimens have comparable efficacy to Biktarvy and may have lower barriers to access in your specific situation. This should be a conversation with your HIV specialist, not a solo decision.
- Contact your congressional representative’s constituent services office. For persistent denials from federal programs, congressional casework offices can sometimes expedite reviews or identify regulatory remedies. This is a legitimate and underused resource.
Never stop antiretroviral therapy without medical guidance. If you are at risk of imminent treatment interruption, call your prescriber today and tell them explicitly: “I am at risk of missing my next dose due to cost.” Prescribers have tools to help — sample supplies, emergency dispensing contacts, and clinical urgency escalations to assistance programs — that are unavailable unless you ask.
Frequently Asked Questions
Biktarvy’s list price is $4,216 per month as of January 2026. Without insurance or assistance, retail cash prices range from $3,800 to over $5,000. However, the majority of uninsured patients qualify for programs that reduce the cost to $0, including Gilead’s Patient Assistance Program, state ADAP programs, and Ryan White clinics.
The most direct path is Gilead’s Patient Assistance Program — call 1-800-226-2056 or apply at GileadAdvancingAccess.com. You will need proof of income, a valid prescription, and documentation that you lack adequate insurance. State ADAP programs offer a parallel government-funded route. Apply to both simultaneously, not sequentially.
Gilead evaluates PAP eligibility on a case-by-case basis. The published guideline is income up to 500% of the federal poverty level — approximately $75,300 for a single person in 2026 — but Gilead states they review each application individually. Patients above this threshold may still be considered depending on their financial circumstances.
You will need: a completed PAP enrollment form signed by your prescriber; proof of income (recent tax return, pay stubs, or signed attestation); proof of insurance status (documentation of no coverage or a coverage denial); and a current, valid Biktarvy prescription. Gilead’s team at 1-800-226-2056 can walk you through requirements for your specific situation.
ADAP is a state-run, federally funded program under the Ryan White HIV/AIDS Program. Unlike Gilead’s PAP, ADAP is a government program with state oversight and typically provides broader services including lab work and clinic visits. Income limits and eligibility vary by state. The two programs are not mutually exclusive — some patients access both.
Yes. All 50 states, DC, Puerto Rico, Guam, and the U.S. Virgin Islands have ADAP programs. Eligibility criteria, income limits, and waiting list status differ by state. Current status can be checked at NASTAD’s ADAP Watch at nastad.org/adap-watch.
Possibly. If your income is at or below 138% FPL and you live in a Medicaid expansion state, you may qualify immediately. Biktarvy is covered by Medicaid in all states, typically with minimal or no copay. Apply at healthcare.gov or your state Medicaid agency. Medicaid has no enrollment period — you can apply any time.
340B clinics are healthcare facilities that purchase drugs at deeply discounted prices under the federal 340B program and pass those savings to patients. Ryan White clinics, FQHCs, and certain hospitals participate. Patients receiving care at these facilities may access Biktarvy at significantly reduced or no cost through the clinic’s in-house or contract pharmacy.
Processing time is typically 2 to 4 weeks from submission of a complete application. Gilead may offer a bridge supply of medication while your application is being processed. Ask explicitly about bridge medication when you call 1-800-226-2056 or when your prescriber submits the enrollment forms.
Ryan White-funded clinics provide comprehensive HIV care regardless of ability to pay, including prescriptions. Use HRSA’s clinic locator at findhivcare.hrsa.gov to find the nearest facility. Federally Qualified Health Centers (FQHCs) also provide sliding-scale care. Do not delay — HIV treatment is most effective when started promptly.
You must notify Gilead and your ADAP program as soon as your insurance status changes. The Gilead PAP is for uninsured patients — if you gain commercial insurance, you will transition to the copay card program. Failing to report insurance changes can affect eligibility.
Yes. Several states operate supplemental HIV assistance programs — California’s Office of AIDS, New York’s AIDS Institute HIPP program, Texas THMP, Illinois ADAP, New Jersey ADAP, Washington HCAM, and Florida’s HIV/AIDS Section each have programs that extend beyond the base ADAP. Your Ryan White clinic can tell you which programs are available in your state.
Yes, though most nonprofit copay programs are primarily designed for insured patients with high cost-sharing. The Patient Advocate Foundation, PAN Foundation, and HealthWell Foundation may cover uninsured patients in some circumstances. Fund availability fluctuates — apply to multiple programs simultaneously and ask about waitlists if a fund is closed.
Your Complete Action List
- Call Gilead Advancing Access: 1-800-226-2056 — ask about PAP eligibility and bridge supply today
- Find your state ADAP program at nastad.org/adap-watch and start enrollment simultaneously
- Check Medicaid eligibility at healthcare.gov/screener if your income is below ~$20,800 (single)
- Find the nearest Ryan White clinic at findhivcare.hrsa.gov and confirm 340B pharmacy availability
- If you are in a non-expansion state, check ACA Marketplace subsidies at kff.org/subsidy-calculator
- Apply to PAF: patientadvocate.org or 1-800-532-5274
- Apply to PAN Foundation: panfoundation.org or 1-866-316-7263
- Apply to HealthWell Foundation: healthwellfoundation.org or 1-800-675-8416
- Find your local AIDS service organization (ASO) at hivcare.org for in-person navigation help
- Ask your prescriber about a bridge supply if you are at risk of missing your next dose
- Do not stop Biktarvy without medical guidance — tell your prescriber if cost is a barrier
How we reviewed this article:
Sunny Pharma follows strict sourcing guidelines and relies on peer-reviewed studies, government agencies (FDA, CMS, HRSA), academic research institutions, and medical associations (DHHS, IDSA). We use only credible, verifiable sources to ensure accuracy. Learn more in our editorial policy.
Sources & References
- Gilead Advancing Access — Patient Assistance: gileadadvancingaccess.com
- Gilead Price Info — Biktarvy WAC: gileadpriceinfo.com
- HRSA — Ryan White HIV/AIDS Program: ryanwhite.hrsa.gov
- NASTAD — ADAP Watch (state-by-state data): nastad.org/adap-watch
- HRSA — Find HIV Care Locator: findhivcare.hrsa.gov
- HRSA — Find a Health Center (FQHC): findahealthcenter.hrsa.gov
- HRSA — 340B Drug Pricing Program: hrsa.gov
- Medicaid.gov — Eligibility: medicaid.gov
- CMS — Medicaid Expansion State Status: kff.org/medicaid
- KFF — ACA Subsidy Calculator: kff.org
- Patient Advocate Foundation: patientadvocate.org
- Patient Access Network Foundation: panfoundation.org
- HealthWell Foundation: healthwellfoundation.org
- NeedyMeds: needymeds.org
- California Office of AIDS: cdph.ca.gov
- New York AIDS Institute: health.ny.gov
- Texas DSHS HIV Medication Program: dshs.texas.gov
- Illinois DPH ADAP: dph.illinois.gov
- HHS Federal Poverty Level Guidelines (2026): healthcare.gov
- FDA — Biktarvy Prescribing Information (2025): accessdata.fda.gov